Table 4.
Multivariate analysis.
| S-SVS (n = 27) | A-SVS (n = 35) | Unadjusted OR (95% CI) | Unadjusted p-value | Adjusted OR (95% CI) | Adjusted p-value | |
|---|---|---|---|---|---|---|
| Technical details | ||||||
| Successful reperfusion | 96% (26/27) | 83% (29/35) | 0.23 (0.03–2.10) | p = 0.194 | 0.04 (0.002–0.58) | p = 0.02 |
| (TICI ≥2b)* | ||||||
| Clinical outcomes | ||||||
| Good clinical outcome | 56% (14/25) | 47% (14/30) | 0.69 (0.24–1.99) | p = 0.49 | 0.72 (0.21–2.46) | p = 0.59 |
| (mRS 0–2)** | ||||||
| Excellent clinical outcome | 44% (11/25) | 23% (7/30) | 0.39 (0.12–1.23) | p = 0.11 | 0.35 (0.09–1.46) | p = 0.15 |
| (mRS 0–1)** | ||||||
| Mortality | 20% (5/25) | 26% (8/30) | 1.46 (0.41–5.18) | p = 0.56 | 3.22 (0.67–15.49) | p = 0.14 |
| (mRS 6)** |
*
Effect of clot shape, adjusted for baseline NIHSS, clot length, with S-SVS as reference group.
**
Effect of clot shape, adjusted for baseline NIHSS, collaterals [HIR], clot length, baseline infarct volume, with S-SVS as reference group.